APO Research
Talk to an analyst

APO RESEARCH · REPORT

Lubiprostone

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Lubiprostone Market Outlook and Growth Opportunities 2026

22 December 2025194 pages

Choose your research edition.

Industry ResearchLubiprostone Industry Research Report 2026103 pages · $2,950 USDIndustry Growth & TrendsGlobal Lubiprostone Industry Growth and Trends Forecast to 203263 pages · $3,450 USDMarket StructureGlobal Lubiprostone Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032179 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lubiprostone Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Lubiprostone Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Lubiprostone market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Lubiprostone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Lubiprostone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Lubiprostone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Lubiprostone market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Lubiprostone market include Takeda Pharmaceuticals. among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Lubiprostone market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Lubiprostone and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Lubiprostone revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Lubiprostone market.

Lubiprostone Segment by Company

Takeda Pharmaceuticals

Lubiprostone Segment by Type

8 mcg Capsules

24 mcg Capsules

Lubiprostone Segment by Application

CIC and OIC

IBS-C

Lubiprostone Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Lubiprostone status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Lubiprostone key companies, revenue, market share, and recent developments.

3. To split the Lubiprostone breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Lubiprostone market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Lubiprostone significant trends, drivers, influence factors in global and regions.

6. To analyze Lubiprostone competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lubiprostone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lubiprostone and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lubiprostone.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Lubiprostone industry.

Chapter 3: Detailed analysis of Lubiprostone company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Lubiprostone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Lubiprostone in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Lubiprostone Industry Trends Table 2. Lubiprostone Industry Drivers Table 3. Lubiprostone Industry Opportunities and Challenges Table 4. Lubiprostone Industry Restraints Table 5. Global Lubiprostone Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Lubiprostone Revenue Share by Company (2021-2026) Table 7. Global Lubiprostone Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Lubiprostone Key Company Manufacturing Base & Headquarters Table 9. Global Lubiprostone Company, Product Type & Application Table 10. Global Lubiprostone Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Lubiprostone by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of 8 mcg Capsules Table 15. Significant Companies of 24 mcg Capsules Table 16. Global Lubiprostone Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Lubiprostone Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Lubiprostone Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Lubiprostone Sales Value Share by Type (2021-2026) Table 20. Global Lubiprostone Sales Value Share by Type (2027-2032) Table 21. Significant Companies of CIC and OIC Table 22. Significant Companies of IBS-C Table 23. Global Lubiprostone Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 24. Global Lubiprostone Sales Value by Application (2021-2026) & (US$ Million) Table 25. Global Lubiprostone Sales Value by Application (2027-2032) & (US$ Million) Table 26. Global Lubiprostone Sales Value Share by Application (2021-2026) Table 27. Global Lubiprostone Sales Value Share by Application (2027-2032) Table 28. Global Lubiprostone Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Lubiprostone Sales Value by Region (2021-2026) & (US$ Million) Table 30. Global Lubiprostone Sales Value Share by Region (2021-2026) Table 31. Global Lubiprostone Sales Value by Region (2027-2032) & (US$ Million) Table 32. Global Lubiprostone Sales Value Share by Region (2027-2032) Table 33. Global Lubiprostone Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Lubiprostone Sales Value by Country (2021-2026) & (US$ Million) Table 35. Global Lubiprostone Sales Value Market Share by Country (2021-2026) Table 36. Global Lubiprostone Sales Value by Country (2027-2032) & (US$ Million) Table 37. Global Lubiprostone Sales Value Market Share by Country (2027-2032) Table 38. Takeda Pharmaceuticals Company Information Table 39. Takeda Pharmaceuticals Business Overview Table 40. Takeda Pharmaceuticals Lubiprostone Revenue (US$ Million) and Gross Margin (2021-2026) Table 41. Takeda Pharmaceuticals Lubiprostone Product Portfolio Table 42. Takeda Pharmaceuticals Recent Development Table 43. Research Programs/Design for This Report Table 44. Authors List of This Report Table 45. Secondary Sources Table 46. Primary Sources List of Figures Figure 1. Lubiprostone Product Image Figure 2. Global Lubiprostone Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Lubiprostone Market Size (2021-2032) & (US$ Million) Figure 4. Global Lubiprostone Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. 8 mcg Capsules Image Figure 8. 24 mcg Capsules Image Figure 9. Global Lubiprostone Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Lubiprostone Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Lubiprostone Sales Value Share by Type (2021-2032) Figure 12. CIC and OIC Image Figure 13. IBS-C Image Figure 14. Global Lubiprostone Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Lubiprostone Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Lubiprostone Sales Value Share by Application (2021-2032) Figure 17. Global Lubiprostone Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Lubiprostone Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 19. North America Lubiprostone Sales Value (2021-2032) & (US$ Million) Figure 20. North America Lubiprostone Sales Value Share by Country (%), 2025 VS 2032 Figure 21. Europe Lubiprostone Sales Value (2021-2032) & (US$ Million) Figure 22. Europe Lubiprostone Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Asia-Pacific Lubiprostone Sales Value (2021-2032) & (US$ Million) Figure 24. Asia-Pacific Lubiprostone Sales Value Share by Country (%), 2025 VS 2032 Figure 25. South America Lubiprostone Sales Value (2021-2032) & (US$ Million) Figure 26. South America Lubiprostone Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Middle East & Africa Lubiprostone Sales Value (2021-2032) & (US$ Million) Figure 28. Middle East & Africa Lubiprostone Sales Value Share by Country (%), 2025 VS 2032 Figure 29. USA Lubiprostone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 30. USA Lubiprostone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 31. USA Lubiprostone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 32. Canada Lubiprostone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. Canada Lubiprostone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. Canada Lubiprostone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Mexico Lubiprostone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Mexico Lubiprostone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Mexico Lubiprostone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Germany Lubiprostone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Germany Lubiprostone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Germany Lubiprostone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. France Lubiprostone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. France Lubiprostone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. France Lubiprostone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. U.K. Lubiprostone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. U.K. Lubiprostone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. U.K. Lubiprostone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Italy Lubiprostone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Italy Lubiprostone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Italy Lubiprostone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Spain Lubiprostone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Spain Lubiprostone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Spain Lubiprostone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Russia Lubiprostone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Russia Lubiprostone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Russia Lubiprostone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Netherlands Lubiprostone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Netherlands Lubiprostone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Netherlands Lubiprostone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Nordic Countries Lubiprostone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Nordic Countries Lubiprostone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Nordic Countries Lubiprostone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. China Lubiprostone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. China Lubiprostone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. China Lubiprostone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Japan Lubiprostone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Japan Lubiprostone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Japan Lubiprostone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. South Korea Lubiprostone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. South Korea Lubiprostone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. South Korea Lubiprostone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. India Lubiprostone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. India Lubiprostone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. India Lubiprostone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Australia Lubiprostone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Australia Lubiprostone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Australia Lubiprostone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Southeast Asia Lubiprostone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Southeast Asia Lubiprostone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Southeast Asia Lubiprostone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Brazil Lubiprostone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Brazil Lubiprostone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Brazil Lubiprostone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Argentina Lubiprostone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Argentina Lubiprostone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Argentina Lubiprostone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Chile Lubiprostone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Chile Lubiprostone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Chile Lubiprostone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Colombia Lubiprostone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Colombia Lubiprostone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Colombia Lubiprostone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Peru Lubiprostone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Peru Lubiprostone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Peru Lubiprostone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Saudi Arabia Lubiprostone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Saudi Arabia Lubiprostone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Lubiprostone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Israel Lubiprostone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Israel Lubiprostone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Israel Lubiprostone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. UAE Lubiprostone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. UAE Lubiprostone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. UAE Lubiprostone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Turkey Lubiprostone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Turkey Lubiprostone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Turkey Lubiprostone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Iran Lubiprostone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Iran Lubiprostone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Iran Lubiprostone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Egypt Lubiprostone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Egypt Lubiprostone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Egypt Lubiprostone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Years Considered Figure 114. Research Process Figure 115. Key Executives Interviewed

Scope & coverage.

Types
  • 8 mcg Capsules
  • 24 mcg Capsules
Applications
  • CIC and OIC
  • IBS-C
Companies covered
  • Takeda Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Lubiprostone Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Lubiprostone Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Lubiprostone Market Dynamics
  1. 2.1 Lubiprostone Industry Trends
  2. 2.2 Lubiprostone Industry Drivers
  3. 2.3 Lubiprostone Industry Opportunities and Challenges
  4. 2.4 Lubiprostone Industry Restraints
3 Lubiprostone Market by Company
  1. 3.1 Global Lubiprostone Company Revenue Ranking in 2025
  2. 3.2 Global Lubiprostone Revenue by Company (2021-2026)
  3. 3.3 Global Lubiprostone Company Ranking (2024-2026)
  4. 3.4 Global Lubiprostone Company Manufacturing Base and Headquarters
  5. 3.5 Global Lubiprostone Company Product Type and Application
  6. 3.6 Global Lubiprostone Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Lubiprostone Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Lubiprostone Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Lubiprostone Market by Type
  1. 4.1 Lubiprostone Type Introduction
  2. 4.1.1 8 mcg Capsules
  3. 4.1.2 24 mcg Capsules
  4. 4.2 Global Lubiprostone Sales Value by Type
  5. 4.2.1 Global Lubiprostone Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Lubiprostone Sales Value by Type (2021-2032)
  7. 4.2.3 Global Lubiprostone Sales Value Share by Type (2021-2032)
5 Lubiprostone Market by Application
  1. 5.1 Lubiprostone Application Introduction
  2. 5.1.1 CIC and OIC
  3. 5.1.2 IBS-C
  4. 5.2 Global Lubiprostone Sales Value by Application
  5. 5.2.1 Global Lubiprostone Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Lubiprostone Sales Value by Application (2021-2032)
  7. 5.2.3 Global Lubiprostone Sales Value Share by Application (2021-2032)
6 Lubiprostone Regional Value Analysis
  1. 6.1 Global Lubiprostone Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Lubiprostone Sales Value by Region (2021-2032)
  3. 6.2.1 Global Lubiprostone Sales Value by Region: 2021-2026
  4. 6.2.2 Global Lubiprostone Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Lubiprostone Sales Value (2021-2032)
  7. 6.3.2 North America Lubiprostone Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Lubiprostone Sales Value (2021-2032)
  10. 6.4.2 Europe Lubiprostone Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Lubiprostone Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Lubiprostone Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Lubiprostone Sales Value (2021-2032)
  16. 6.6.2 South America Lubiprostone Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Lubiprostone Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Lubiprostone Sales Value Share by Country, 2025 VS 2032
7 Lubiprostone Country-level Value Analysis
  1. 7.1 Global Lubiprostone Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Lubiprostone Sales Value by Country (2021-2032)
  3. 7.2.1 Global Lubiprostone Sales Value by Country (2021-2026)
  4. 7.2.2 Global Lubiprostone Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Lubiprostone Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Lubiprostone Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Lubiprostone Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Lubiprostone Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Lubiprostone Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Lubiprostone Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Lubiprostone Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Lubiprostone Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Lubiprostone Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Lubiprostone Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Lubiprostone Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Lubiprostone Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Lubiprostone Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Lubiprostone Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Lubiprostone Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Lubiprostone Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Lubiprostone Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Lubiprostone Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Lubiprostone Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Lubiprostone Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Lubiprostone Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Lubiprostone Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Lubiprostone Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Lubiprostone Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Lubiprostone Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Lubiprostone Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Lubiprostone Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Lubiprostone Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Lubiprostone Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Lubiprostone Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Lubiprostone Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Lubiprostone Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Lubiprostone Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Lubiprostone Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Lubiprostone Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Lubiprostone Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Lubiprostone Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Lubiprostone Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Lubiprostone Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Lubiprostone Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Lubiprostone Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Lubiprostone Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Lubiprostone Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Lubiprostone Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Lubiprostone Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Lubiprostone Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Lubiprostone Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Lubiprostone Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Lubiprostone Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Lubiprostone Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Lubiprostone Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Lubiprostone Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Lubiprostone Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Lubiprostone Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Lubiprostone Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Lubiprostone Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Lubiprostone Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Lubiprostone Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Lubiprostone Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Lubiprostone Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Lubiprostone Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Lubiprostone Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Lubiprostone Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Lubiprostone Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Lubiprostone Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Lubiprostone Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Lubiprostone Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Lubiprostone Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Lubiprostone Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Lubiprostone Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Lubiprostone Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Lubiprostone Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Lubiprostone Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Lubiprostone Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Lubiprostone Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Lubiprostone Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Lubiprostone Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Lubiprostone Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Lubiprostone Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Lubiprostone Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Lubiprostone Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Lubiprostone Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Lubiprostone Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Lubiprostone Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Takeda Pharmaceuticals
  2. 8.1.1 Takeda Pharmaceuticals Company Information
  3. 8.1.2 Takeda Pharmaceuticals Business Overview
  4. 8.1.3 Takeda Pharmaceuticals Lubiprostone Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Takeda Pharmaceuticals Lubiprostone Product Portfolio
  6. 8.1.5 Takeda Pharmaceuticals Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst